Translational Development Acquisition Corp. (NASDAQ:TDACU – Get Free Report)’s share price dropped 5.2% on Wednesday. The stock traded as low as $12.11 and last traded at $11.4810. 202 shares changed hands during trading, a decline of 91% from the average session volume of 2,185 shares. The stock had previously closed at $12.11.
Translational Development Acquisition Trading Down 4.4%
The business has a fifty day simple moving average of $12.17 and a two-hundred day simple moving average of $11.66.
Translational Development Acquisition Company Profile
Translational Development Acquisition Corporation is a special purpose acquisition company (SPAC) formed to identify and complete a business combination with one or more operating companies. Rather than selling products or services of its own, the company raises capital through a public offering and holds those funds while it evaluates potential merger, acquisition, or similar opportunities.
The company has indicated that it is seeking a target in the healthcare and life sciences sectors, although its business activities may change substantially if it completes a transaction.
Read More
- Five stocks we like better than Translational Development Acquisition
- Alphabet Introduces Gemini Agent—Can It Trigger a Breakout?
- Palantir’s Rally Puts Wall Street in Catch-Up Mode Ahead of November Earnings
- Tilray Finds a Path to Growth Without Waiting on U.S. Cannabis Reform
- Arista Networks Plugs Into All-Time Highs
Receive News & Ratings for Translational Development Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Translational Development Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.
